Texas Medical Specialty, Inc. has been at the forefront of developing overly sensitive, reliable medical assays for COVID Testing, cancer gene testing and HLA testing with the shortest turnaround time in the industry. One of our biggest priorities is working with laboratory researchers and physicians to develop tests to diagnose diseases and monitor rejection and acceptance responses in patients requiring an organ transplantation. We strive for perfection in all our testing services, and our organization is uniquely optimized to provide these services at an affordable cost.
Meet the Director
Dr. Afzal Nikaein, PHD, President and Director of Texas Medical Specialty, Inc., has devoted many years to performing research in the field of transplantation. Her ongoing interest includes being able to detect rejection or tolerance which would help in monitoring transplant recipients and better managing their immunosuppressive drug intake.
Our Accreditation and Certification
At Texas Medical Specialty, Inc., our laboratory testing and practices carefully follow standards set by the American Society for Histocompatibility and Immunogenetics (ASHI), by the Clinical Laboratory Improvement Act (CLIA), College of American Pathologist(CAP) and by United Network for Organ Sharing (UNOS).